Cargando…
Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors
BACKGROUND: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in cancer therapy, particularly in the treatment of B-cell malignancies. However, optimization of CAR-T cell production remains a trial-and-error exercise due to a lack of phenotypic benchmarks that are clea...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457995/ https://www.ncbi.nlm.nih.gov/pubmed/25990251 http://dx.doi.org/10.1186/s12967-015-0519-8 |
_version_ | 1782375037112680448 |
---|---|
author | Chang, ZeNan L. Silver, Pamela A. Chen, Yvonne Y. |
author_facet | Chang, ZeNan L. Silver, Pamela A. Chen, Yvonne Y. |
author_sort | Chang, ZeNan L. |
collection | PubMed |
description | BACKGROUND: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in cancer therapy, particularly in the treatment of B-cell malignancies. However, optimization of CAR-T cell production remains a trial-and-error exercise due to a lack of phenotypic benchmarks that are clearly predictive of anti-tumor functionality. A close examination of the dynamic changes experienced by CAR-T cells upon stimulation can improve understanding of CAR–T-cell biology and identify potential points for optimization in the production of highly functional T cells. METHODS: Primary human T cells expressing a second-generation, anti-CD19 CAR were systematically examined for changes in phenotypic and functional responses to antigen exposure over time. Multi-color flow cytometry was performed to quantify dynamic changes in CAR-T cell viability, proliferation, as well as expression of various activation and exhaustion markers in response to varied antigen stimulation conditions. RESULTS: Stimulated CAR-T cells consistently bifurcate into two distinct subpopulations, only one of which (CAR(hi)/CD25(+)) exhibit anti-tumor functions. The use of central memory T cells as the starting population and the resilience—but not antigen density—of antigen-presenting cells used to expand CAR-T cells were identified as critical parameters that augment the production of functionally superior T cells. We further demonstrate that the CAR(hi)/CD25(+) subpopulation upregulates PD-1 but is resistant to PD-L1-induced dysfunction. CONCLUSIONS: CAR-T cells expanded ex vivo for adoptive T-cell therapy undergo dynamic phenotypic changes during the expansion process and result in two distinct populations with dramatically different functional capacities. Significant and sustained CD25 and CAR expression upregulation is predictive of robust anti-tumor functionality in antigen-stimulated T cells, despite their correlation with persistent PD-1 upregulation. The functionally superior subpopulation can be selectively augmented by careful calibration of antigen stimulation and the enrichment of central memory T-cell type. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0519-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4457995 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44579952015-06-07 Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors Chang, ZeNan L. Silver, Pamela A. Chen, Yvonne Y. J Transl Med Research BACKGROUND: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in cancer therapy, particularly in the treatment of B-cell malignancies. However, optimization of CAR-T cell production remains a trial-and-error exercise due to a lack of phenotypic benchmarks that are clearly predictive of anti-tumor functionality. A close examination of the dynamic changes experienced by CAR-T cells upon stimulation can improve understanding of CAR–T-cell biology and identify potential points for optimization in the production of highly functional T cells. METHODS: Primary human T cells expressing a second-generation, anti-CD19 CAR were systematically examined for changes in phenotypic and functional responses to antigen exposure over time. Multi-color flow cytometry was performed to quantify dynamic changes in CAR-T cell viability, proliferation, as well as expression of various activation and exhaustion markers in response to varied antigen stimulation conditions. RESULTS: Stimulated CAR-T cells consistently bifurcate into two distinct subpopulations, only one of which (CAR(hi)/CD25(+)) exhibit anti-tumor functions. The use of central memory T cells as the starting population and the resilience—but not antigen density—of antigen-presenting cells used to expand CAR-T cells were identified as critical parameters that augment the production of functionally superior T cells. We further demonstrate that the CAR(hi)/CD25(+) subpopulation upregulates PD-1 but is resistant to PD-L1-induced dysfunction. CONCLUSIONS: CAR-T cells expanded ex vivo for adoptive T-cell therapy undergo dynamic phenotypic changes during the expansion process and result in two distinct populations with dramatically different functional capacities. Significant and sustained CD25 and CAR expression upregulation is predictive of robust anti-tumor functionality in antigen-stimulated T cells, despite their correlation with persistent PD-1 upregulation. The functionally superior subpopulation can be selectively augmented by careful calibration of antigen stimulation and the enrichment of central memory T-cell type. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0519-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-05-20 /pmc/articles/PMC4457995/ /pubmed/25990251 http://dx.doi.org/10.1186/s12967-015-0519-8 Text en © Chang et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Chang, ZeNan L. Silver, Pamela A. Chen, Yvonne Y. Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors |
title | Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors |
title_full | Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors |
title_fullStr | Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors |
title_full_unstemmed | Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors |
title_short | Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors |
title_sort | identification and selective expansion of functionally superior t cells expressing chimeric antigen receptors |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457995/ https://www.ncbi.nlm.nih.gov/pubmed/25990251 http://dx.doi.org/10.1186/s12967-015-0519-8 |
work_keys_str_mv | AT changzenanl identificationandselectiveexpansionoffunctionallysuperiortcellsexpressingchimericantigenreceptors AT silverpamelaa identificationandselectiveexpansionoffunctionallysuperiortcellsexpressingchimericantigenreceptors AT chenyvonney identificationandselectiveexpansionoffunctionallysuperiortcellsexpressingchimericantigenreceptors |